Melanocortin Arousal & Bonding Stack
MC4R + Oxytocin Pathway Research Model
A two-compound hormonal research model targeting sexual arousal and social bonding through independent but convergent neuroendocrine pathways.
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist with selectivity for MC3R and MC4R subtypes expressed in the hypothalamus and spinal cord. Unlike PDE5 inhibitors, PT-141 acts centrally on CNS arousal circuits rather than peripheral vascular tissue. Oxytocin is a nonapeptide synthesized in hypothalamic paraventricular and supraoptic nuclei acting on oxytocin receptors (OXTR) in the limbic system to modulate pair-bonding, social reward, and prosocial behavior.
Key Research Areas
- Dual-pathway melanocortin and oxytocinergic signaling research
- CNS arousal circuit activation investigation
- Social bonding and reward pathway interaction studies
- Neuroendocrine model independent of gonadal hormone status
Research Applications
- Melanocortin receptor pharmacology and CNS arousal studies
- Oxytocinergic bonding and limbic reward circuit research
- Neuroendocrine cross-talk in social and sexual behavior models
- MC4R agonist interaction with hypothalamic neuropeptide systems
Bundle Savings
This research stack includes a 10% discount compared to purchasing compounds individually. All components are third-party tested with Certificates of Analysis available for each batch.
For research use only. Not for human or animal consumption.